Ranbaxy Laboratories has reportedly received US Food and Drug Administration (US FDA) approval for a particular drug called Plendil generic. The drug is used for hypertension. The company was expected to be the authorised generic for this particular drug, but it is already genericised and there are already 6-7 players in this market for this particular drug.
For Ranbaxy this is the first approval that they have received from the USFDA after two years, after the Lipitor generic received approval.
Ranbaxy Laboratories, India’s largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.
For Ranbaxy this is the first approval that they have received from the USFDA after two years, after the Lipitor generic received approval.
Ranbaxy Laboratories, India’s largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies.
No comments:
Post a Comment